| Dioxins, dioxin-like PCBs and non-dioxin-like PCBs in foodstuffs: occurrence and dietary intake in The Netherlands AJ Baars, MI Bakker, RA Baumann, PE Boon, JI Freijer, ... Toxicology letters 151 (1), 51-61, 2004 | 350 | 2004 |
| Extensions to the visual predictive check to facilitate model performance evaluation TM Post, JI Freijer, BA Ploeger, M Danhof Journal of pharmacokinetics and pharmacodynamics 35, 185-202, 2008 | 230 | 2008 |
| Relation between bioavailability and fuel oil hydrocarbon composition in contaminated soils H de Jonge, JI Freijer, JM Verstraten, J Westerveld, FWM Van der Wielen Environmental science & technology 31 (3), 771-775, 1997 | 169 | 1997 |
| Particle size-dependent total mass deposition in lungs determines inhalation toxicity of cadmium chloride aerosols in rats. Application of a multiple path dosimetry model FR Cassee, H Muijser, E Duistermaat, JJ Freijer, KB Geerse, ... Archives of toxicology 76, 277-286, 2002 | 145 | 2002 |
| Comparison of six methods to determine unsaturated soil hydraulic conductivity J Stolte, JI Freijer, W Bouten, C Dirksen, JM Halbertsma, JC Van Dam, ... Soil Science Society of America Journal 58 (6), 1596-1603, 1994 | 113 | 1994 |
| Disease system analysis: basic disease progression models in degenerative disease TM Post, JI Freijer, J DeJongh, M Danhof Pharmaceutical research 22, 1038-1049, 2005 | 111 | 2005 |
| A comparison of field methods for measuring soil carbon dioxide evolution: experiments and simulation JI Freijer, W Bouten Plant and Soil 135, 133-142, 1991 | 103 | 1991 |
| Risk assessment of deoxynivalenol in food: concentration limits, exposure and effects MN Pieters, J Freijer, BJ Baars, DCM Fiolet, J van Klaveren, W Slob Mycotoxins and Food Safety, 235-248, 2002 | 93 | 2002 |
| Novel Δ9‐tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects LE Klumpers, TL Beumer, JGC van Hasselt, A Lipplaa, LB Karger, ... British journal of clinical pharmacology 74 (1), 42-53, 2012 | 90 | 2012 |
| Population pharmacokinetic model of THC integrates oral, intravenous, and pulmonary dosing and characterizes short-and long-term pharmacokinetics JAAC Heuberger, Z Guan, OO Oyetayo, L Klumpers, PD Morrison, ... Clinical pharmacokinetics 54, 209-219, 2015 | 85 | 2015 |
| The VOLASOIL risk assessment model based on CSOIL for soils contaminated with volatile compounds MFW Waitz, JI Freijer, P Kreule, FA Swartjes Rijksinstituut voor Volksgezondheid en Milieu RIVM, 1996 | 82 | 1996 |
| Calibration of jointed tube model for the gas diffusion coefficient in soils JI Freijer Soil Science Society of America Journal 58 (4), 1067-1076, 1994 | 80 | 1994 |
| First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug development A Strougo, T Eissing, A Yassen, S Willmann, M Danhof, J Freijer Journal of pharmacokinetics and pharmacodynamics 39, 195-203, 2012 | 75 | 2012 |
| Population pharmacokinetic modelling of non‐linear brain distribution of morphine: influence of active saturable influx and P‐glycoprotein mediated efflux D Groenendaal, J Freijer, D De Mik, MR Bouw, M Danhof, ECM De Lange British journal of pharmacology 151 (5), 701-712, 2007 | 71 | 2007 |
| Modeling relationships between indoor and outdoor air quality JI Freijer, HJT Bloemen Journal of the Air & Waste Management Association 50 (2), 292-300, 2000 | 71 | 2000 |
| Analysis of lobar differences in particle deposition in the human lung RP Subramaniam, B Asgharian, JI Freijer, FJ Miller, S Anjilvel Inhalation toxicology 15 (1), 1-21, 2003 | 69 | 2003 |
| Adapted Fick's law applied to soil respiration JI Freijer, PA Leffelaar Water Resources Research 32 (4), 791-800, 1996 | 63 | 1996 |
| Assessing mineralization rates of petroleum hydrocarbons in soils in relation to environmental factors and experimental scale JI Freijer, H De Jonge, W Bouten, JM Verstraten Biodegradation 7, 487-500, 1996 | 44 | 1996 |
| Predicting the “First dose in children” of CYP3A‐metabolized drugs: Evaluation of scaling approaches and insights into the CYP3A7‐CYP3A4 switch at young ages A Strougo, A Yassen, C Monnereau, M Danhof, J Freijer The Journal of Clinical Pharmacology 54 (9), 1006-1015, 2014 | 43 | 2014 |
| Pharmacokinetic/pharmacodynamic modelling of the EEG effects of opioids: the role of complex biophase distribution kinetics D Groenendaal, J Freijer, A Rosier, D de Mik, G Nicholls, A Hersey, ... European journal of pharmaceutical sciences 34 (2-3), 149-163, 2008 | 39 | 2008 |
